Advertisement

Medical and Health Problems in Adults with High-Functioning Autism and Asperger Syndrome

  • Lillian Burke
  • Kevin P. Stoddart
Chapter

Abstract

Adults on the autism spectrum experience a wide range of medical and health problems—some at a higher prevalence compared with the general population. Although these problems can significantly affect quality of life, information on medical comorbidities for this group is sparse, and general knowledge of disorders associated with autism spectrum disorder (ASD) in community-based medical settings is lacking. In this chapter, we review medical and health problems experienced by adults with ASD. We begin this discussion by examining possible risk factors associated with health problems in this group, in addition to the current literature on prevalence rates of specific disorders. The focus of this chapter is on those who have historically been identified with “high-functioning autism” or Asperger syndrome.

Keywords

Autism Spectrum Disorder Autism Spectrum Disorder Irritable Bowel Syndrome Celiac Disease Anorexia Nervosa 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Adams, J. B., Audhya, T., McDonough-Means, S., Rubin, R. A., Quig, D., Geis, E., et al. (2011). Nutritional and metabolic status of children with autism vs. neurotypical children, and the association with autism severity. Nutrition and Metabolism, 8(1), 34.PubMedCentralPubMedCrossRefGoogle Scholar
  2. Akins, R. S., Angkustsiri, K., & Hansen, R. L. (2010). Complementary and alternative medicine in autism: An evidence-based approach to negotiating safe and efficacious interventions with families. Neurotherapeutics, 7(3), 307–319.PubMedCrossRefGoogle Scholar
  3. Ali, S., Moriarity, J., Mullatti, N., & David, A. (2006). Psychiatric comorbidity in adult patients with hypothalamic hamartoma. Epilepsy and Behavior, 9, 111–118.PubMedCrossRefGoogle Scholar
  4. American Diabetes Association. (1999). American Diabetes Association complete guide to diabetes (2nd ed.). Alexandria, VI: American Diabetes Association.Google Scholar
  5. Anagnostou, E., & Hansen, R. L. (2011). Medical treatment overview: Traditional and novel psycho-pharmacological and complementary and alternative medications. Current Opinion in Pediatrics, 23(6), 621–627.PubMedCrossRefGoogle Scholar
  6. Ashwood, P., Wills, S., & Water, J. (2006). The immune response in autism: A few frontier for autism research. Journal of Leukocyte Biology, 80, 1–15.PubMedCrossRefGoogle Scholar
  7. Atladottir, H., Pedersen, M. G., Scient, C., Thorsen, P., Mortensen, P. B., Deleuran, B., et al. (2009). Association of family history of autoimmune diseases and autism spectrum disorders. Pediatrics, 124(2), 687–694.PubMedCrossRefGoogle Scholar
  8. Attwood, T. (2007). The complete guide to Asperger’s syndrome. London: Jessica Kingsley.Google Scholar
  9. Balfe, M., & Tantum, D. (2010). A descriptive social and health profile of a community sample of adults and adolescents with Asperger syndrome. BMC Research Notes, 3, 300.PubMedCentralPubMedCrossRefGoogle Scholar
  10. Barnhill, G. A. (2007). Outcomes in adults with Asperger syndrome. Focus on Autism and Other Developmental Disabilities, 22(2), 116–126.CrossRefGoogle Scholar
  11. Baron-Cohen, S., Mortimore, C., Moriarty, J., Izaguirre, J., & Robertson, M. (1999). The prevalence of Gilles de la Tourette’s syndrome in children and adolescents with autism. Journal of Child Psychology and Psychiatry, and Allied Disciplines, 40(2), 213–218.PubMedCrossRefGoogle Scholar
  12. Berney, T. (2004). Asperger syndrome from childhood into adulthood. Advances in Psychiatric Treatment, 10(5), 341–351.CrossRefGoogle Scholar
  13. Bolton, P. F., Park, R. J., Higgins, J. N. P., Griffiths, P. D., & Pickles, A. (2002). Neuro-epileptic determinants of autism spectrum disorders in tuberous sclerosis complex. Brain, 125(6), 1247–1255.PubMedCrossRefGoogle Scholar
  14. Bourne, F. M., & Howard, R. P. (1963). Addison’s disease complicating diabetes. Canadian Medical Association Journal, 88, 365–368.PubMedCentralPubMedGoogle Scholar
  15. Brewer, E. J. (1986). Pitfalls in the diagnosis of juvenile rheumatoid arthritis. The Pediatric Clinics of North America, 33(5), 1015–1032.Google Scholar
  16. Brosnan, M., Turner-Cobb, J., Munro-Naan, Z., & Jessop, D. (2009). Absence of normal cortisol awakening response (CAR) in adolescent males with Asperger syndrome (AS). Psychoneuroendocrinology, 34(7), 1095–1100.PubMedCrossRefGoogle Scholar
  17. Brown, A., Chow, D., Goh, W., Kwee, S., LeRoy, M., & Murakami, S. (2010). Possible gastrointestinal symptoms in a subset of children with autism. Expert Review of Gastroenterology and Hepatology, 4(2), 125–127.PubMedCrossRefGoogle Scholar
  18. Bruder, M. B., Kerins, G., Mazzarella, C., Sims, J., & Stein, N. (2012). The medical care of adults with autism spectrum disorders: Identifying the needs. Journal of Autism and Developmental Disorders, 42(11), 2498–2504.PubMedCrossRefGoogle Scholar
  19. Burgoine, E., & Wing, L. (1983). Identical triplets with Asperger’s syndrome. British Journal of Psychiatry, 143(3), 261–265.PubMedCrossRefGoogle Scholar
  20. Burke, L. (2005). Psychological assessment of more able adults. In K. P. Stoddart (Ed.), Children, youth and adults with Asperger syndrome: Integrating multiple perspectives (pp. 211–225). London: Jessica Kingsley.Google Scholar
  21. Burke, L., Stoddart, K. P., & Abdelsayed, S. (2012). Females on the autism spectrum: A profile of 60 women. Poster presented at the Geneva Centre for Autism International Conference, Toronto, ON, October 2012.Google Scholar
  22. Campbell, D. B., Buie, T. M., Winter, H., Bauman, M., Sutcliffe, J. F., Perrin, J. M., et al. (2009). Distinct genetic risk based on associate of MET in families with co-occurring autism and gastrointestinal conditions. NeoReviews, 123(3), 1018–1024.Google Scholar
  23. Cederlund, M., & Gillberg, C. (2004). One hundred males with Asperger syndrome: A clinical study of background and associated factors. Developmental Medicine and Child Neurology, 46(10), 652–660.PubMedCrossRefGoogle Scholar
  24. Chen, M., Su, T., Chen, Y., Hsu, J., Huang, K., Chang, W., et al. (2013). Comorbidity of allergic and autoimmune diseases in patients with autism spectrum disorder: A nationwide population-based study. Research in Autism Spectrum Disorders, 7(2), 205–212.CrossRefGoogle Scholar
  25. Clauw, D. J. (2009). Fibromyalgia: An overview. The American Journal of Medicine, 122(12 Supplement), S3–S13.PubMedCrossRefGoogle Scholar
  26. Coombs, E., Brosnan, M., Bryant-Waugh, R., & Skevinton, S. M. (2011). An investigation into the relationship between eating disorder psychopathology and autistic symptomatology in a non-clinical sample. British Journal of Clinical Psychology, 50(3), 326–338.PubMedCrossRefGoogle Scholar
  27. Cross-Disorder Group of the Psychiatric Genomics Consortium. (2013). Identification of risk loci with shared effects on five major psychiatric disorders: A genome-wide analysis. The Lancet, 381(9875), 1371–1379. doi: 10.1016/S0140-6736(12)62129-1.CrossRefGoogle Scholar
  28. De Hert, M., Dobbelaere, M., Sheridan, E. M., Cohen, D., & Correll, C. U. (2011). Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practice. European Psychiatry, 26, 144–158.PubMedCrossRefGoogle Scholar
  29. Denmark, J. L. (2002). The relationship between autism and fragile X syndrome: A review of the research. Journal on Developmental Disabilities, 9(2), 29–43.Google Scholar
  30. Devendra, D., Lui, E., & Eisenbarth, G. S. (2004). Type 1 diabetes: Recent developments. BMJ, 328, 750–754.PubMedCentralPubMedCrossRefGoogle Scholar
  31. Dodd, S. (2005). Understanding autism. Australia: Elsevier.Google Scholar
  32. Dominick, K. C., Davis, N. O., Lainhart, J., Tager-Flusberg, H., & Folstein, S. (2007). Atypical behaviors in children with autism and children with a history of language impairment. Research in Developmental Disabilities, 28(2), 145–162.PubMedCrossRefGoogle Scholar
  33. Egerton, R. B., Bollinger, M., & Herr, B. (1984). The cloak of competence: After two decades. American Journal of Mental Deficiency, 88(4), 345–351.Google Scholar
  34. Epstein, T., & Salzman-Benaiah, J. (2005). Tourette syndrome and Asperger syndrome: Overlapping symptoms and treatment implications. In K. P. Stoddart (Ed.), Children, youth and adults with Asperger syndrome: Integrating multiple perspectives (pp. 72–83). London: Jessica Kingsley.Google Scholar
  35. Erickson, C. A., Stigler, K. A., Corkins, M. R., Posey, D. J., Fitzgerald, J. F., & McDougle, C. J. (2005). Gastrointestinal factors in autistic disorder: A critical review. Journal of Autism and Developmental Disorders, 35(6), 713–727.PubMedCrossRefGoogle Scholar
  36. Freeman, R. D., Fast, D. K., Burd, L., Kerbeshian, J., Robertson, M. M., & Sandor, P. (2000). An international perspective on Tourette syndrome: Selected findings from 3500 individuals in 22 countries. Developmental Medicine & Child Neurology, 42(7), 436–447.CrossRefGoogle Scholar
  37. Freeman, S. J., Roberts, W., & Daneman, D. (2005). Type 1 diabetes and autism: Is there a link? Diabetes Care, 28(4), 925–926.PubMedCrossRefGoogle Scholar
  38. Garber, K. B., Visootsak, J., & Warren, S. T. (2008). Fragile X syndrome. European Journal of Human Genetics, 16(6), 666–672.PubMedCrossRefGoogle Scholar
  39. Garner, D. M. (1998). The effects of starvation on behavior: Implications for dieting and eating disorders. Healthy Weight Journal, September/October, 68–72.Google Scholar
  40. Gilger, M. A., & Redel, C. A. (2009). Autism and the gut. Pediatrics, 124(2), 796–798.PubMedCrossRefGoogle Scholar
  41. Gillberg, C. (1992). Subgroups in autism: Are there behavioural phenotypes typical of underlying medical conditions? Journal of Intellectual Disability Research, 36, 201–214.PubMedCrossRefGoogle Scholar
  42. Gillberg, C. (2002). A guide to Asperger syndrome. Cambridge, England: Cambridge University Press.CrossRefGoogle Scholar
  43. Gillberg, C., & Billstedt, E. (2000). Autism and Asperger syndrome: Coexistence with other clinical disorders. Acta Psychiatrica Scandinavica, 102(5), 321–330.PubMedCrossRefGoogle Scholar
  44. Gillberg, C., Billstedt, E., Sundh, V., & Gillberg, I. C. (2010). Mortality in autism: A prospective longitudinal community-based study. Journal of Autism and Developmental Disorders, 40(3), 352–357.PubMedCrossRefGoogle Scholar
  45. Gillberg, C., & Ehlers, S. (1998). High-functioning people with autism and Asperger syndrome: A literature review. In E. Schopler, G. B. Mesibov, & L. J. Kunce (Eds.), Asperger syndrome or high-functioning autism? (pp. 79–106). New York: Plenum Press.CrossRefGoogle Scholar
  46. Gillberg, I. C., Gillberg, C., & Kopp, S. (1992). Hypothyroidism and autism spectrum disorders. Journal of Child Psychology and Psychiatry, 33(3), 531–542.PubMedCrossRefGoogle Scholar
  47. Graetz, J. (2010). Autism grows up: Opportunities for adults with autism. Disability and Society, 25(1), 33–47.CrossRefGoogle Scholar
  48. Grandin, T. (2009, May/June). Hidden medical problems can cause behavior problems. Autism Asperger’s Digest.Google Scholar
  49. Hamza, R. T., Hewedi, D., & Ismail, M. A. (2010). Basal and adrenocorticotropic hormone stimulated plasma cortisol levels among Egyptian autistic children: Relation to disease severity. Italian Journal of Pediatrics, 36, 71.PubMedCentralPubMedCrossRefGoogle Scholar
  50. Hendriksen, J. G. M., & Vles, J. S. H. (2008). Neuropsychiatric disorders in males with Duchenne muscular dystrophy: Frequency rate of attention-deficit hyperactivity disorder (ADHA), autism spectrum disorder, and obsessive-compulsive disorder. Journal of Child Neurology, 23(5), 477–481.PubMedCrossRefGoogle Scholar
  51. Holden, J. J. A., & Liu, X. (2005). The genetics of autism spectrum disorders. In K. P. Stoddart (Ed.), Children, youth and adults with Asperger syndrome: Integrating multiple perspectives (pp. 268–281). London: Jessica Kingsley.Google Scholar
  52. Hoshiko, S., Grether, J. K., Windham, G. C., Smith, D., & Fessel, K. (2011). Are thyroid hormone concentrations at birth associated with subsequent autism diagnosis? Autism Research, 4(6), 456–463.PubMedCrossRefGoogle Scholar
  53. Howden, C. W., & Chey, W. D. (2003). Gastroesophageal reflux disease. The Journal of Family Practice, 52(3), 240–247.PubMedGoogle Scholar
  54. Iasger, T., Mouridsen, S. E., & Rich, B. (1999). Mortality and causes of death in pervasive developmental disorders. Autism, 3(1), 7–16.CrossRefGoogle Scholar
  55. Iwata, K., Matsuzaki, H., Miyachi, T., Shimmura, C., Suda, S., Tsuchiya, K. J., et al. (2011). Investigation of serum levels of anterior pituitary hormones in male children with autism. Molecular Autism, 2, 16.PubMedCentralPubMedCrossRefGoogle Scholar
  56. James, I. A., Mukaetova-Ladinska, E., Reichelt, F. K., Briel, R., & Scully, A. (2006). Diagnosing Aspergers syndrome in the elderly: A series of case presentations. International Journal of Geriatric Psychiatry, 21, 951–960.PubMedCrossRefGoogle Scholar
  57. Jankovic, J. (2001). Tourette’s syndrome. New England Journal of Medicine, 345(16), 1184–1192.PubMedCrossRefGoogle Scholar
  58. Jin, Y., Mailloux, C. M., Gowan, K., Riccardi, S. L., LaBerge, G., Bennett, D. C., et al. (2007). NALP1 in vitiligo-associated autoimmune disease. New England Journal of Medicine, 356, 1216–1225.PubMedCrossRefGoogle Scholar
  59. Jones, P. B., & Kerwin, R. W. (1990). Left temporal lobe damage in Asperger’s syndrome. The British Journal of Psychiatry, 156(4), 570–572.PubMedCrossRefGoogle Scholar
  60. Kahrilas, P. J. (2003). GERD pathogenesis, pathophysiology and clinical manifestations. Cleveland Clinic Journal of Medicine, 70(5), S4–S19.PubMedCrossRefGoogle Scholar
  61. Kalyva, E. (2009). Comparison of eating attitudes between adolescent girls with and without Asperger syndrome: Daughters’ and mothers’ reports. Journal of Autism and Developmental Disorders, 39(3), 480–486.PubMedCrossRefGoogle Scholar
  62. Kerbeshian, J., & Burd, L. (1996). Case study: Comorbidity among Tourette syndrome, autistic disorder, and bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 681–685.PubMedCrossRefGoogle Scholar
  63. Klauck, S. M. (2006). Genetics of autism spectrum disorder. European Journal of Human Genetics, 14(6), 714–720.PubMedCrossRefGoogle Scholar
  64. Kohane, I. S., McMurry, A., Weber, G., MacFadden, D., Rappaport, L., Kunkel, L., et al. (2012). The co-morbidity burden of children and young adults with autism spectrum disorders. PLoS One, 7(4), e33224. Epub April 2012.PubMedCentralPubMedCrossRefGoogle Scholar
  65. Krakowiak, P., Walker, C. K., Bremer, A. A., Baker, A. S., Ozonoff, S., Hansen, R. L., et al. (2012). Maternal metabolic conditions and risk for autism and other neurodevelopmental disorders. Pediatrics, 129(5), e1121–e1128. doi: 10.1542/peds.2011-2583.PubMedCentralPubMedCrossRefGoogle Scholar
  66. Kring, S. R., Greenberg, J. S., & Mailick Seltzer, M. (2010). The impact of health problems on behavior problems in adolescents and adults with autism spectrum disorders: Implications for maternal burden. Social Work and Mental Health, 8, 54–71.CrossRefGoogle Scholar
  67. Laiho, K., & Meckelburg, K. (2003). Rheumatoid arthritis in a patient with Asperger’s syndrome and IDDM. Clinical Rheumatology, 22, 361–362.PubMedCrossRefGoogle Scholar
  68. Lawton, S. C., & Reichenberg-Ullman, J. (2007). Asperger syndrome: Natural steps toward a better life. Santa Barbara, CA: Greenwood Publishing.Google Scholar
  69. Leehey, M. A., Legg, W., Tassone, F., & Hagerman, R. (2011). Fibromyalgia in fragile X mental retardation 1 gene permutation carriers. Rheumatology, 50(12), 2233–2236.PubMedCentralPubMedCrossRefGoogle Scholar
  70. Lopata, C., Volker, M., Putnam, S., Thomeer, M., & Nida, R. (2008). Effect of social familiarity on salivary cortisol and self-reports of social anxiety and stress in children with high functioning autism spectrum disorders. Journal of Autism and Developmental Disorders, 38(10), 1866–1877.PubMedCrossRefGoogle Scholar
  71. Lynch, M. E. (2004). A report of the parent initiated use of dietary interventions and nutritional supplements as a treatment for individuals with an autism spectrum disorder. International Journal of Disability, Community & Rehabilitation, 3(4), 1–17.Google Scholar
  72. Mahoney, W. (2002). Dual diagnosis in children. In D. Griffiths, C. Stavrakaki, & J. Summers (Eds.), Dual diagnosis: An introduction to the mental health needs of persons with developmental disabilities (pp. 483–507). Sudbury, ON: Habilitative Mental Health Resource Network.Google Scholar
  73. Marriage, K. J., Miles, T., Stokes, D., & Davey, M. (1993). Clinical and research implications of the co-occurrence of Asperger’s and Tourette syndromes. Australian & New Zealand Journal of Psychiatry, 27(4), 666–672.CrossRefGoogle Scholar
  74. Miles, J. H., McCathern, R. B., Stichter, J. P., & Shinawi, M. (2010). Autism spectrum disorders in: GeneReviews at GeneTests: Medical genetics information resource, University of Washington, Seattle, WA, 1997–2010. Available at http://www.genetests.org.
  75. Molloy, C. A., Morrow, A. L., Meinzen-Derr, J., Dawson, G., Bernier, R., Dunn, M., et al. (2006). Familial autoimmune thyroid disease as a risk factor for regression in children with autism spectrum disorder: A CPEA study. Journal of Autism and Developmental Disorders, 36(3), 317–324.PubMedCrossRefGoogle Scholar
  76. Mouridsen, S. E., & Sorensen, S. A. (1995). Psychological aspects of von Recklinghausen neurofibromatosis (NF1). Journal of Medical Genetics, 32(12), 921–924.PubMedCentralPubMedCrossRefGoogle Scholar
  77. Mousseau, C., Ludkin, R., Szatmari, P., & Bryson, S. E. (2006). Current issues for more able adults with autism spectrum disorder: An examination of quality of life, mental health, and physical wellbeing. Hamilton, ON: Woodview Manor.Google Scholar
  78. Murray, J. A. (1999). The widening spectrum of celiac disease. American Journal of Clinical Nutrition, 69(3), 354–365.PubMedGoogle Scholar
  79. Muskat, B., Nicholas, D., Roberts, S. W., Stoddart, K. P., Zwaigenbaum, L., & Burnham Riosa, P. (2012). Autism comes to the hospital: Experiences of hospital care from the perspectives of children and adolescents with ASD, their parents, and health care providers. Poster presentation at Geneva Centre for Autism International Symposium on Autism, Toronto, ON, October 2012.Google Scholar
  80. National Institute of Child Health and Human Development (NICHD). (2003). Families and fragile X syndrome (NIH Publication No. 96-302). Rockville, MD: U.S. Government Printing Office.Google Scholar
  81. Nicolaidis, C., Raymaker, D., McDonald, K., Dern, S., Boisclair, C., Ashkenazy, E., et al. (2013). Comparison of healthcare experiences in autistic and non-autistic adults: A cross-sectional online survey facilitated by an academic-community partnership. Journal of General Internal Medicine, 28(6), 761–769. doi: 10.1007/s1 1606-012-2262-7.PubMedCrossRefGoogle Scholar
  82. Nikolov, R. N., Bearss, K. E., Lettinga, J., Erickson, C., Rodowski, M., Aman, M. G., et al. (2009). Gastrointestinal symptoms in a sample of children with pervasive developmental disorders. Journal of Autism and Developmental Disorders, 39(3), 405–413.PubMedCrossRefGoogle Scholar
  83. Percy, M., & Propst, E. (2008). Celiac disease: Its many faces and relevance to developmental disability. Journal on Developmental Disabilities, 14(2), 105–110.Google Scholar
  84. Povey, C., Mills, R., & Gomez de la Cuesta, G. (2011). Autism and ageing: Issues for the future. Geriatric Medicine, 2011(April), 230–232.Google Scholar
  85. Poysky, J. (2007). Behavior patterns in Duchene muscular dystrophy: Report on the parent project muscular dystrophy behavior workshop 8–9 December 2006, Philadelphia. Neuromuscular Disorders, 17(11–12), 986–994.PubMedCrossRefGoogle Scholar
  86. Raja, M., Azzoni, A., & Giammarco, V. (1998). Diabetes insipidus and polydipsia in a patient with Asperger’s disorder and an empty sella: A case report. Journal of Autism and Developmental Disorders, 28(3), 235–239.PubMedCrossRefGoogle Scholar
  87. Rao, S. G., Gendreau, J. F., & Kranzler, J. D. (2008). Understanding the fibromyalgia syndrome. Psychopharmacology Bulletin, 40(4), 24–56.Google Scholar
  88. Ringman, J. M., & Jankovic, J. (2000). Occurrence of tics in Asperger’s syndrome and autistic disorder. Journal of Child Neurology, 15(6), 394–400.PubMedCrossRefGoogle Scholar
  89. Ritvo, E. R., Ritvo, R., Freeman, B. J., & Mason-Brothers, A. (1994). Clinical characteristics of mild autism in adults. Comprehensive Psychiatry, 35(2), 149–156.PubMedCrossRefGoogle Scholar
  90. Roberts, S. W., & Kagan-Kushnir, T. (2005). Integrating paediatrics and child development: Asperger syndrome and the role of the developmental paediatrician. In K. P. Stoddart (Ed.), Children, youth and adults with Asperger syndrome: Integrating multiple perspectives (pp. 140–154). London: Jessica Kingsley.Google Scholar
  91. Salyakina, D., Ma, D. Q., Jaworski, J. M., Konidari, I., Whitehead, P. L., Henson, R., et al. (2010). Variants in several genomic regions associated with Asperger disorder. Autism Research, 3(6), 303–310.PubMedCrossRefGoogle Scholar
  92. Schaaf, C. P., & Zoghbi, H. Y. (2011). Solving the autism puzzle a few pieces at a time. Neuron, 70(5), 806–808. doi: 10.1016/j.neuron.2011.05.025.PubMedCrossRefGoogle Scholar
  93. Searcy, E., Burd, L., Kerbeshian, J., Stenehjem, A., & Franceschini, L. A. (2000). Asperger’s syndrome, X-linked mental retardation (MRX23), and chronic vocal tic disorder. Journal of Child Neurology, 15(10), 699–702.PubMedCrossRefGoogle Scholar
  94. Seltzer, M. M., Greenberg, J. S., Hong, J., Smith, L. E., Almeida, D. M., Coe, C., et al. (2009). Maternal cortisol levels and behavior problems in adolescents and adults with ASD. Journal of Autism and Developmental Disorders, 40, 457–469.CrossRefGoogle Scholar
  95. Seltzer, M. M., & Wyngaarden Kraus, M. (undated). Report #7: Health-related needs for adolescents and adults with autism and their parents. Retrieved from www.waisman.wisc.edu/family/study_autism.html
  96. Shattock, P., & Whiteley, P. (2002). Biochemical aspects in autism spectrum disorders: Updating the opioid-excess theory and presenting new opportunities for biomedical intervention. Expert Opinion on Therapeutic Targets, 6(2), 175–183.PubMedCrossRefGoogle Scholar
  97. Shattuck, P. T., Roux, A. M., Hudson, L. E., Taylor, J. L., Maenner, M. J., & Trani, J. (2012). Services for adults with an autism spectrum disorder. Canadian Journal of Psychiatry, 57(5), 284–291.Google Scholar
  98. Shavelle, R. M., Strauss, D. J., & Pickett, J. (2001). Causes of death in autism. Journal of Autism and Developmental Disorders, 31(6), 569–576.PubMedCrossRefGoogle Scholar
  99. Sherman, S. (2002). Epidemiology. In R. J. Hagerman & P. J. Hagerman (Eds.), Fragile X syndrome: Diagnosis, treatment and research (3rd ed.). Baltimore: John Hopkins University Press.Google Scholar
  100. Sicile-Kira, C. (2004). Autism spectrum disorders: The complete guide to understanding autism, Asperger’s syndrome, pervasive developmental disorder and other ASD. New York: Perigee Books.Google Scholar
  101. Sloman, L. (2005). Medication use in children with high-functioning pervasive developmental disorder and Asperger syndrome. In K. P. Stoddart (Ed.), Children, youth and adults with Asperger syndropme: Integrating multiple perspectives (pp. 168–183). London: Jessica Kingsley.Google Scholar
  102. Spence, S. J., Sharifi, P., & Wiznitzer, M. (2004). Autism spectrum disorder: Screening, diagnosis, and medical evaluation. Seminars in Pediatric Neurology, 11, 186–195.PubMedCrossRefGoogle Scholar
  103. Spiller, R. C. (2005). Irritable bowel syndrome. British Medical Bulletin, 72(1), 15–29.PubMedCrossRefGoogle Scholar
  104. Spratt, E. G., Nicholas, J. S., Brady, K. T., Carpenter, L. A., Hatcher, C. R., Meekins, K. A., et al. (2012). Enhanced cortical response to stress in children with autism. Journal of Autism and Developmental Disorders, 42(1), 75–81.PubMedCentralPubMedCrossRefGoogle Scholar
  105. St. Amanda, R. P., & Marek, C. C. (1999). What your doctor may not tell you about fibromyalgia: The revolutionary treatment that can reverse the disease. New York: Warner Books.Google Scholar
  106. Steinhart, H. A. (2012). Crohn’s & colitis: Understand and managing IBD (2nd ed.). Toronto, ON: Robert Rose.Google Scholar
  107. Stoddart, K. P. (2005). Introduction to Asperger syndrome: A developmental lifespan perspective. In K. P. Stoddart (Ed.), Children, youth and adults with Asperger syndrome: Integrating multiple perspectives (pp. 13–30). London: Jessica Kingsley.Google Scholar
  108. Stoddart, K. P. (2006). Aging and autism spectrum disorders. In: The 15th roundtable on aging and intellectual disabilities, International Association for the Scientific Study of Intellectual Disabilities, University of Toronto, Toronto, ON, April 2006.Google Scholar
  109. Stoddart, K. P., Burke, L., & King, R. (2012). Asperger syndrome in adulthood: A comprehensive guide for clinicians. New York: Norton Professional Books.Google Scholar
  110. Stoddart, K. P., Burke, L., Muskat, B., Manett, J., Duhaime, S., Accardi, C., et al. (2013). Diversity in Ontario’s youth and adults with autism spectrum disorders: Complex needs in an unprepared systems. Toronto, ON: The Redpath Centre.Google Scholar
  111. Stoddart, K. P., Burke, L., & Temple, V. (2002). The clinical needs and characteristics of adults with autism spectrum disorders: A review of 100 cases. State of the HART: Habilitative Achievements in Research and Treatment for Mental Health in Developmental Disabilities. UBC Department of Continuing Education, Vancouver, BC, April 2002.Google Scholar
  112. Sverd, J. (1991). Tourette syndrome and autistic disorder: A significant relationship. American Journal of Medical Genetics, 39(2), 173–179.PubMedCrossRefGoogle Scholar
  113. Sweeten, T. L., Bowyer, S. L., Posey, T. J., Halberstadt, G. M., & McDougle, C. J. (2003). Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders. Pediatrics, 112, e420. doi: 10.1542/peds.112.5.e420.PubMedCrossRefGoogle Scholar
  114. Tani, P., Lindberg, N., Matto, V., Appelberg, B., Nieminen-von Wendt, T., von Wendt, L., et al. (2005). Higher plasma ACTH levels in adults with Asperger syndrome. Journal of Psychosomatic Research, 58, 533–536.PubMedCrossRefGoogle Scholar
  115. Taylor, D. C., Neville, B. G. R., & Cross, J. H. (1999). Autistic spectrum disorders in childhood epilepsy surgery candidates. European Child and Adolescent Psychiatry, 8(3), 189–192.PubMedCrossRefGoogle Scholar
  116. Teitelbaum, J. (2011, June 30). Is autism related to CFS and fibromyalgia? The nutrient L-carnitine appears effective in treating all three. Psychology Today.Google Scholar
  117. Ten, S., New, M., & MacLaren, N. (2001). Clinical review 130: Addison’s disease 2001. The Journal of Clinical Endocrinology and Metabolism, 86(7), 2909–2922.PubMedGoogle Scholar
  118. Torres, A. R., Westover, J. B., & Rosenspire, A. J. (2012). HLA immune function genes in autism. Autism Research and Treatment, 2012, 959073. doi: 10.1155/2012.959073.PubMedCentralPubMedCrossRefGoogle Scholar
  119. Towbin, K. E. (2003). Strategies for pharmacologic treatment of high functioning autism and Asperger syndrome. Child and Adolescent Psychiatric Clinics of North America, 12(1), 23–45.PubMedCrossRefGoogle Scholar
  120. Warwick, T. C., Griffith, J., Reyes, B., Legesse, B., & Evans, M. (2007). Effects of vagus nerve stimulation in a patient with temporal lobe epilepsy and Asperger syndrome: Case report and review of the literature. Epilepsy and Behavior, 10(2), 344–347.PubMedCrossRefGoogle Scholar
  121. Wentz, E., Lacey, J. H., Waller, G., Rastem, M., Turk, J., & Gillberg, C. (2005). Childhood onset neuropsychiatric disorders in adult eating disorder patients: A pilot study. European Child & Adolescent Psychiatry, 14(8), 431–437.CrossRefGoogle Scholar
  122. Wilbarger, J. L., & Cook, D. B. (2011). Multisensory hypersensitivity in women with fibromyalgia: Implications for wellbeing and intervention. Archives of Physical Medicine and Rehabilitation, 92(4), 653–656.PubMedCentralPubMedCrossRefGoogle Scholar
  123. Willemsen-Swinkels, S. H., & Buitelaar, J. K. (2002). The autistic spectrum: Subgroups, boundaries, and treatment. Psychiatric Clinics of North America, 25(4), 811–836.PubMedCrossRefGoogle Scholar
  124. Williams, P. G., & Hersch, J. H. (1998). Brief report: The association of neurofibromatosis Type 1 and autism. Journal of Autism and Developmental Disorders, 28(6), 567–571.PubMedCrossRefGoogle Scholar
  125. Wiznitzer, M. (2004). Autism and tuberous sclerosis. Journal of Child Neurology, 29(9), 675–679.Google Scholar
  126. World Health Organization (WHO). (2011a). World report on disability. Geneva, Switzerland: WHO Press.Google Scholar
  127. World Health Organization (WHO). (2011b). World conference on social determinants of health: Meeting report, Rio de Janeiro, Brazil, October 19–21, 2011.Google Scholar
  128. Yates, J. R. W. (2006). Tuberous sclerosis. European Journal of Human Genetics, 14, 1065–1073.PubMedCrossRefGoogle Scholar
  129. Young, J. L., & Redmond, J. C. (2007). Fibromyalgia, chronic fatigue, and adult attention deficit hyperactivity disorder in the adult: A case study. Psychopharmacology Bulletin, 40(1), 118–126.PubMedGoogle Scholar
  130. Yunus, M. B. (2012). The prevalence of fibromyalgia in other chronic pain conditions. Pain and Research Treatment, 2012, 584573. doi: 10.1155/2012/584573.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.The Redpath CentreTorontoCanada
  2. 2.The Redpath Centre and University of TorontoTorontoCanada

Personalised recommendations